Explore Company News Direct From Our Network
Global News from Our Network.
Search and filter the results by company or location to find the news that matters to you.
If you would like to publish news on behalf of your company, please register with us at the following link https://www.pharmaservicesdirectory.com/register
Save
This Search |
View as Grid
| Order by Recently Added
| Order
by Company Name
- Total Results: 1,413
- Total Pages: 177
uBriGene Cellinfinity In Vivo CAR-T Partnership
Germantown, MD - March 30, 2026 - uBriGene Biosciences (uBriGene), a leading global CDMO specializing in lentiviral vector manufacturing and Advanced Therapy Medicinal Product (ATMP) development, today announced a strategic partnership with Cellinfinity BIO, a biotechnology company developing in vivo CAR-T therapies targeting hematologic and solid tumors. This strategic partnership will accelerate the clinical advancement of Cellinfinity…
Read more on this story »
Services Profile
Blue Ocean Robotics appoints PSC Biotech Corporation as new partner for pharmaceutical sector
Denmark / United States / Australia / Singapore - Blue Ocean Robotics, who is a leading provider of autonomous UV-C disinfection solutions, is pleased to announce a new distributor agreement with PSC Biotech. Through this distributor agreement, PSC Biotech will distribute the UVD Robot Pharma platform across the United States, Australia, and Singapore, bringing autonomous UV-C disinfection technology to pharmaceutical manufacturers who wish to improve their Annex 1 and contamination control strategies.The UVD Robot Pharma is designed specifically for cleanroom…
Read more on this story »
Services Profile
NJ Bio, Inc. and Ajinomoto Bio-Pharma Services Partner to Advance ADC and AOC Development
NJ Bio, Inc. and Ajinomoto Bio-Pharma Services have announced a collaboration aimed at expanding access to advanced antibody-drug conjugate (ADC) technologies for biopharma innovators. Under the agreement, NJ Bio will integrate Ajinomoto’s proprietary AJICAP™ site-specific conjugation platform into its discovery and early development workflows. The partnership is expected to enhance NJ Bio’s capabilities in antibody conjugation and linker technologies, enabling more precise and reproducible development of targeted therapeutics. NJ Bio believes this technology…
Read more on this story »
Services Profile
Biocytogen and Sihuan Pharmaceutical Announce Strategic Partnership in Weight Loss and Beyond
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced a strategic partnership with Sihuan Pharmaceutical Holdings Group Ltd. (Sihuan Pharmaceutical; HKEX: 00460). Under the agreement, both parties will combine Biocytogen’s leading fully human antibody discovery platform with Sihuan Pharmaceutical’s extensive capabilities in drug development, manufacturing,…
Read more on this story »
Services Profile
UCB licenses Antengene’s ATG-201 for autoimmune diseases
HONG KONG and BRUSSELS - Antengene Corporation Limited and UCB announced today they have entered into a worldwide exclusive licensing agreement for ATG-201, a CD19/CD3 bispecific T-cell engager antibody targeting B cell-related autoimmune diseases, according to a press release statement. Under the agreement, UCB receives worldwide exclusive rights to develop, manufacture and commercialize ATG-201. Antengene will receive $80 million in upfront and near-term milestone payments, comprising an initial $60 million upfront payment and an additional $20 million upon…
Read more on this story »
Services Profile
Secarna Pharmaceuticals and Curie.Bio Expand Existing Partnership
Martinsried (Munich), Germany, March 3, 2026 - Secarna Pharmaceuticals GmbH & Co. KG, a company redefining the discovery and development of best-in-class oligonucleotide therapeutics today announced the expansion of the existing scientific and strategic collaboration agreement with Curie.Bio announced in May 2025. The expansion includes Secarna’s support in identifying oligonucleotide candidates using its proprietary OligoCreator® platform for research and development projects conducted by Curie.Bio portfolio companies.
View original story »
Services Profile
Peli BioThermal Announces Strategic Partnership with Polar Group in Brazil
MAPLE GROVE, Minn., March 2, 2026 /PRNewswire/ -- Peli BioThermal, a global provider of temperature-controlled packaging solutions for the life sciences industry, today announced a strategic partnership with Polar Group to expand the availability of its reusable and single-use cold chain solutions across Brazil.
View original story »
Services Profile
Cellipont Bioservices and Soter Bio Announce Strategic Collaboration to Support Integrated U.S. Cell Therapy Manufacturing
The Woodlands, Texas— February 24, 2026/ Cision / – Cellipont Bioservices, a leading cell therapy Contract Development and Manufacturing Organization (CDMO), today announced a strategic collaboration with Soter Bio, a CDMO specializing in RNA and RNA–lipid nanoparticle (LNP) manufacturing for research and GMP applications. Together, the companies will support integrated manufacturing pathways for complex cell therapy programs requiring coordinated biomolecule and cellular processing.
View original story »
Services Profile
- Total Results: 1,413
- Total Pages: 177
Network News
Keeping the latest and up-to-date news on our companies is a key activity of the editorial team.
We support companies directly through the profiles to allow them update their profile with the latest news and company announcements. Search fields are provided so that you can access news by company name, sector e.g research, manufacturing, equipment, packaging or geography.
The global news is updated daily and its aim is to provide you as a directory user with the information needed to make good buying or supply choices. News covers companies operating within the pharmaceutical, biotechnology, medical device and nutraceutical sectors.
Also through our software applications you can evaluate, rate and score news and company announcements to support corporate risk management activities. Through the software applications it is possible to supplement and add your own news items, keeping a library of news activities on any company identified through the directory.
Take the Next Step
Should you have any questions or require further information please contact us ...
Contact the support team »
Check if your company is listed and claim your online profile ...
Search for your company listing »
If you're not listed in the directory and you want to build a public profile, register for an account ...
Register for an account to build a profile »
Apply for a free trial of our Supplier Management Software ...
Register for an account to trial the software »
